Introduction

dbDNA™ replaces plasmid DNA in AAV manufacturing, reducing material requirements while eliminating bacterial sequences to enhance purity and efficiency.

High-efficiency AAV constructs for scalable vector development.

Designed for maximum performance, our AAV reporter and packaging constructs offer high-purity solutions for efficient viral vector assembly. Engineered to support research and clinical applications, these constructs ensure reproducible results, enabling rapid validation and large-scale production. With optimised precision, dbDNA™ enhances the safety and scalability of AAV workflows, providing a reliable foundation for gene therapy development, all supported by our expert applications specialists to guide you at every step of the process.

  • High-purity DNA for improved efficiency and safety
  • Essential packaging components for reliable vector assembly
  • Lower DNA requirements without compromising viral titres
  • Ready-to-use constructs for seamless research integration
  • GMP-compliant material for clinical applications
  • Scalable production for regulatory approval readiness
Description

Click More Info for details.